Literature DB >> 25368824

A rare case of polycythemia vera following acute undifferentiated leukemia remission.

Hee-Jeong Youk1, Chi-Hyun Cho1, Jong-Han Lee1, Chul Won Choi2, Chae Seung Lim1, Soo-Young Yoon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25368824      PMCID： PMC4215407          DOI： 10.3343/alm.2014.34.6.469

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN： 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  10 in total

1.  De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.

Authors:  Craig A Portell; Mikkael A Sekeres; Heesun J Rogers; Ramon V Tiu
Journal:  Br J Haematol       Date:  2011-12-08       Impact factor: 6.998

2.  Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance.

Authors:  Elisabetta Antonioli; Paola Guglielmelli; Giada Poli; Valeria Santini; Alberto Bosi; Alessandro M Vannucchi
Journal:  Blood       Date:  2007-12-15       Impact factor: 22.113

3.  Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report.

Authors:  A Belotti; E Doni; E Elli; V Rossi; P Pioltelli; E M Pogliani
Journal:  Acta Haematol       Date:  2011-03-31       Impact factor: 2.195

4.  A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.

Authors:  F Passamonti; E Rumi; D Pietra; C Elena; E Boveri; L Arcaini; E Roncoroni; C Astori; M Merli; S Boggi; C Pascutto; M Lazzarino; M Cazzola
Journal:  Leukemia       Date:  2010-07-15       Impact factor: 11.528

5.  A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission.

Authors:  C Chabannon; M Bost; D Hollard
Journal:  Leukemia       Date:  1994-07       Impact factor: 11.528

6.  JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.

Authors:  Dong Wook Jekarl; Sang Bong Han; Myungshin Kim; Jihyang Lim; Eun-Jee Oh; Yonggoo Kim; Hee-Je Kim; Woo-Sung Min; Kyungja Han
Journal:  Korean J Hematol       Date:  2010-03-31

Review 7.  The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia.

Authors:  Hun Ju Lee; Naval Daver; Hagop M Kantarjian; Srdan Verstovsek; Farhad Ravandi
Journal:  Clin Cancer Res       Date:  2012-12-03       Impact factor: 12.531

8.  Novel immunophenotypic and morphologic presentation in acute myeloid leukemia (AML) with JAK2 V617F mutation.

Authors:  Suchitra Swaminathan; Manisha Madkaikar; Kanjaksha Ghosh; Babu Rao Vundinti; Lily Kerketta; Maya Gupta
Journal:  Eur J Haematol       Date:  2009-10-12       Impact factor: 2.997

9.  Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation.

Authors:  Naseema Gangat; Jacob Strand; Chin-Yang Li; Wenting Wu; Animesh Pardanani; Ayalew Tefferi
Journal:  Br J Haematol       Date:  2007-08       Impact factor: 6.998

10.  Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.

Authors:  Ayalew Tefferi
Journal:  Am J Hematol       Date:  2013-06       Impact factor: 10.047
  10 in total
  3 in total

1.  An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone.

Authors:  Beatrice Borsellino; Arianna Savi; Maria Rosaria Pascale; Elisa Meddi; Maria Ilaria Del Principe; Antonio Cristiano; Tiziana Ottone; Maria Cristina Rapanotti; Mariadomenica Divona; Serena Travaglini; Enrico Attardi; Raffaele Palmieri; Elisa Buzzatti; Francesco Buccisano; Maria Teresa Voso
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

2.  DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.

Authors:  Preetesh Jain; Srdan Verstovsek; Wei Wang; Sanam Loghavi; Harrys A Torres; Zeev Estrov; Keyur P Patel; Naveen Pemmaraju
Journal:  Leuk Lymphoma       Date:  2015-12-24

3.  Polycythemia vera emerging eighteen years after acute myeloid leukemia diagnosis.

Authors:  Stephen E Langabeer; Derick W O'Flynn; Mary R Cahill
Journal:  Blood Res       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.